Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Net Sales
755.81
Other Operating Income
0.00
Total Operating income
755.81
Raw Material Cost
194.14
Purchase of Finished goods
0.00
(Increase) / Decrease In Stocks
0.00
Employee Cost
122.66
Power Cost
0.00
Manufacturing Expenses
158.10
Selling and Distribution Expenses
0.00
Other Expenses
114.27
Total Expenditure (Excl Depreciation)
589.17
Operating Profit (PBDIT) excl Other Income
166.64
Other Income
14.10
Operating Profit (PBDIT)
180.74
Interest
20.83
Exceptional Items
0.00
Gross Profit (PBDT)
159.91
Depreciation
72.47
Profit Before Tax
87.44
Tax
20.34
Provisions and contingencies
0.00
Profit After Tax
67.10
Extraordinary Items
0.00
Prior Period Expenses
0.00
Other Adjustments
0.00
Net Profit
67.10
Share in Profit of Associates
0.00
Minority Interest
0.00
Other related items
0.00
Consolidated Net Profit
67.10
Equity Capital
1.77
Face Value
10.0
Reserves
578.68
Earnings per share (EPS)
379.1
Diluted Earnings per share
380.1
Operating Profit Margin (Excl OI)
22.05%
Gross Profit Margin
21.16%
PAT Margin
8.88%
Public Share Holdings (%)
0.0%
Pledged Promotor Holding (%)
0.0%
Annual Analysis Highlights
Analysis not available as Data has been published for only 1 period
Compare Annual Results Of Nephrocare Healt With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
755.81
687.35
68.46
9.96%
Other Operating Income
0.00
0.00
0.00
Total Operating income
755.81
687.35
68.46
9.96%
Raw Material Cost
194.14
188.27
5.87
3.12%
Purchase of Finished goods
0.00
2.00
-2.00
-100.00%
(Increase) / Decrease In Stocks
0.00
0.81
-0.81
-100.00%
Employee Cost
122.66
126.77
-4.11
-3.24%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
158.10
0.00
158.10
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
114.27
179.14
-64.87
-36.21%
Total Expenditure (Excl Depreciation)
589.17
496.99
92.18
18.55%
Operating Profit (PBDIT) excl Other Income
166.64
190.36
-23.72
-12.46%
Other Income
14.10
14.83
-0.73
-4.92%
Operating Profit (PBDIT)
180.74
205.19
-24.45
-11.92%
Interest
20.83
3.05
17.78
582.95%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
159.91
202.14
-42.23
-20.89%
Depreciation
72.47
55.26
17.21
31.14%
Profit Before Tax
87.44
146.88
-59.44
-40.47%
Tax
20.34
54.69
-34.35
-62.81%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
67.10
92.19
-25.09
-27.22%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
67.10
92.19
-25.09
-27.22%
Share in Profit of Associates
0.00
-1.44
1.44
100.00%
Minority Interest
0.00
0.76
-0.76
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
67.10
91.51
-24.41
-26.67%
Equity Capital
1.77
52.99
-51.22
-96.66%
Face Value
10.00
10.00
0.00
Reserves
578.68
493.76
84.92
17.20%
Earnings per share (EPS)
379.10
5.76
373.34
6,481.60%
Diluted Earnings per share
380.10
5.69
374.41
6,580.14%
Operating Profit Margin (Excl OI)
22.05%
27.69%
0.00
-5.64%
Gross Profit Margin
21.16%
29.41%
0.00
-8.25%
PAT Margin
8.88%
13.20%
0.00
-4.32%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 543.60 Cr
in Mar 2025Figures in Cr
Annual - Standalone Net Profit
Standalone Net Profit 34.24 Cr
in Mar 2025Figures in Cr
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 94.89 Cr
in Mar 2025Figures in Cr
Annual - Interest
Interest 14.30 Cr
in Mar 2025Figures in Cr
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.46%
in Mar 2025Figures in %






